22
total announcements
HIKAL.NS · 15 min delayed
Hikal Limited
Hikal Limited has informed the Exchange about a scheduled meeting with analysts and institutional investors on September 4, 2026, at the company's Pune R&T centre.
Hikal Limited
Hikal Limited has informed the Exchange about Copy of Newspaper Publication regarding the 38th Annual General Meeting and information on e-Voting.
Hikal Limited
Hikal Limited has informed the Exchange about General Updates, including the notice of 38th Annual General Meeting (AGM) and Annual Report for the Financial Year 2025-26. The company has also requested shareholders to update their KYC details and dematerialize physical securities.
Hikal Limited
Hikal Limited has informed the Exchange about General Updates, including the Annual Report for Financial Year 2025-26 and Notice of the 38th Annual General Meeting (AGM) of the Company.
Hikal Limited
Hikal Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026.
Hikal Limited
Hikal Limited has informed the Exchange regarding 'Communication to Shareholders-Intimation of Tax Deduction on Dividend'. The company has recommended a Final Dividend of Rs. 0.40/- paise per equity share for the Financial Year ended March 31, 2026, and the said Final Dividend will be payable post approval of the shareholders at the ensuing 38th Annual General Meeting (“AGM”) of the Company to be held on Wednesday, September 23, 2026.
Hikal Limited
Hikal Limited has informed the Exchange about Copy of Newspaper Publication regarding information about 38th Annual General Meeting of the Company and other related information.
Hikal Limited
Hikal Limited has informed the Exchange about General Updates, including the 38th Annual General Meeting (AGM) scheduled on September 23, 2026, and the Record Date for Final Dividend for the Financial Year 2025-26 fixed on September 04, 2026.
Hikal Limited
Hikal Limited has fixed September 4, 2026, as the record date for determining the eligibility of members for payment of final dividend for the financial year 2025-26.
Hikal Limited
Hikal Limited has informed the Exchange regarding Outcome of Board Meeting held on August 26, 2026, where the Board of Directors unanimously approved the appointment of Mr. Sameer Hiremath as Chairman and Managing Director of the Company for a period of 5 years, subject to approval of the shareholders at the ensuing Annual General Meeting.
Hikal Limited
Hikal Limited has informed the Exchange about opening a special window for transfer and dematerialisation of physical securities, as per SEBI Circular No. HO/38/13/11 (2)2026-MIRSD-POD/ 1/3750/2026 dated January 30, 2026.
Hikal Limited
Hikal Limited has announced its Q1 FY27 earnings conference call transcript, highlighting its recovery journey from a regulatory-led disruption last year to execution-led growth. The company reported revenue of Rs 403 crores with an EBITDA margin of 9.2% in Q1 FY27, driven by improving customer ordering patterns and product mix.
Hikal Limited
Hikal Limited has informed the Exchange about the newspaper publication of its unaudited financial results for Q1'FY27.
Hikal Limited
Hikal Limited has made available the audio recording of its earnings group conference call for the quarter ended June 30, 2026, on its website.
Hikal Limited
Hikal Limited announced its unaudited financial results for the quarter ended June 30, 2026, with revenue at Rs. 403 Crs and EBITDA margin expanding 260 bps YoY. The company's pharmaceutical business delivered revenue of Rs. 233 Cr in Q1FY27, growth of 15.2% YoY, while the crop protection business witnessed improved domestic demand in the Own Products segment.
Hikal Limited
Hikal Limited has informed the Exchange about the presentation of unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company reported revenue of ₹403 Cr. with an EBITDA margin of 9.2%. The Pharmaceutical business is in the penultimate stage of its remediation plan with the US FDA, while the Crop Protection business witnessed improved domestic demand in the Own Products segment.
Hikal Limited
Hikal Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and the trading window for designated persons will reopen on August 9, 2026.
Hikal Limited
Hikal Limited has informed the Exchange about Schedule of meet for Q1 FY27 Post Results Conference Call on Thursday, 6th August 2026 at 05:00 PM (IST). The conference call will be attended by Mr. Sameer Hiremath, Vice Chairman and Managing Director, Mr. Anish Swadi, Senior President, Business Transformation and Animal Health, Mr. Kuldeep Jain, Chief Financial Officer, and Mr. Manoj Mehrotra, President, Pharmaceuticals Business.
Hikal Limited
Hikal Limited has been awarded the EcoVadis Gold Medal rating, placing it among the top 5% of more than 175,000 companies assessed globally by EcoVadis each year.
Hikal Limited
Hikal Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.